Printer Friendly

SMITHKLINE BEECHAM APPLIES FOR TOKYO STOCK EXCHANGE LISTING

       SMITHKLINE BEECHAM APPLIES FOR TOKYO STOCK EXCHANGE LISTING
    PHILADELPHIA, Nov. 11 /PRNewswire/ -- An application has been filed today with the Japanese Ministry of Finance for approval for listing of the "A" Ordinary Shares of SmithKline Beecham (SB) plc on the Tokyo Stock Exchange.
    It is expected that the shares will be listed and trading will commence early in December.  The application has been sponsored by Daiwa Securities Co. Ltd.
    No new shares will be issued in connection with the listing.
    /delval/
    -0-                        11/11/91
    /CONTACT:  Sharyn Arnold, 215-751-7074, or Richard Williams (financial), 215-751-7002, both of SmithKline Beecham/
    (SBH) CO:  SmithKline Beecham; Daiwa Securities Co. Ltd. ST:  Pennsylvania IN:  MTC SU: MP -- PH002 -- 2948 11/11/91 10:20 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 11, 1991
Words:120
Previous Article:HUTCHINSON TECHNOLOGY REPORTS FOURTH QUARTER RESULTS
Next Article:McDONALD'S OPENS FIRST RESTAURANT IN GREECE GOLDEN ARCHES NOW IN 56 COUNTRIES
Topics:


Related Articles
SMITHKLINE BEECHAM APPLIES FOR TOKYO STOCK EXCHANGE LISTING
SMITHKLINE BEECHAM AND EDS ANNOUNCE A JOINT MARKETING AGREEMENT
SMITHKLINE BEECHAM SHARE STRUCTURE SIMPLIFICATION COMPLETED; COMPANY ADOPTS NEW STOCK SYMBOLS 'SBH' ON NYSE, 'SB.' ON LONDON EXCHANGE
SMITHKLINE BEECHAM FILES SHELF REGISTRATION
Corixa Corporation Establishes Cancer Vaccine Research Collaboration and License Agreement With SmithKline Beecham Biologicals
Corixa and SmithKline Beecham Biologicals Extend Tuberculosis Collaboration
TSE suspends trading in Glaxo Wellcome on merger report.
ArQule Announces Drug Discovery Collaboration with SmithKline Beecham.
Glaxo Wellcome and SmithKline Beecham Merger Update: Completion Planned for December 27, 2000.
Glaxo Wellcome and SmithKline Beecham Merger Update: US Regulatory Clearance Obtained.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters